A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
Stewart AK, Bergsagel PL, Greipp PR, Dispenzieri A, Gertz MA, Hayman SR, Kumar S, Lacy MQ, Lust JA, Russell SJ, Witzig TE, Zeldenrust SR, Dingli D, Reeder CB, Roy V, Kyle RA, Rajkumar SV, Fonseca R.
Stewart AK, et al. Among authors: greipp pr.
Leukemia. 2007 Mar;21(3):529-34. doi: 10.1038/sj.leu.2404516. Epub 2007 Jan 18.
Leukemia. 2007.
PMID: 17230230